MARKER THERAPEUTICS INCMARKER THERAPEUTICS INCMARKER THERAPEUTICS INC

MARKER THERAPEUTICS INC

No trades
See on Supercharts

GX1 fundamentals

MARKER THERAPEUTICS INC revenue breakdown overview

MARKER THERAPEUTICS INC revenue for the last year amounted to 3.00 M EUR, the most of which — 3.00 M EUR — came from its highest performing source at the moment, Immunotherapies and Innovative Peptide-Based Vaccines, the year earlier bringing 8.42 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MARKER THERAPEUTICS INC 3.00 M EUR, and the year before that — 8.42 M EUR.

By source
By country